Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

FET or huff FET; huff The FET involves carefully exhaling with the mouth and glottis open to generate mild dynamic ... Acute exacerbation of chronic obstructive pulmonary disease; COPD: Chronic ...

A study was undertaken to investigate the sputum cell and cytokine characteristics of COPD when stable and during an exacerbation. METHODS Induced sputum samples from 57 patients with moderate to ...

In the MANDALA trial, Airsupra was found to significant reduce the risk of severe exacerbations compared ... in patients with mild to moderate asthma. In terms of safety and tolerability, in ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...

Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...